ARCHIVES

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

This article is from The Cancer Letter archive.

Vol. 37 No. 05 | February 4, 2011

Download PDF Visit The Full Archive

Related Articles

Professional Fundraiser Poses Eight Questions For SU2C 3.

September 19, 2008

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

August 2, 1991

Radiotherapy In Combination With Zometa Provide Pain Control For Advanced Myeloma

February 27, 2004

ONS Urges Congress To Back Anti-Tobacco Measures.

July 20, 2001

Some NCAB Members Lack Understanding f Bypass Budget’s Value, Purpose

September 1, 1989

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003